- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
104 Cards in this Set
- Front
- Back
|
Which amino acids are important for ketogenesis?
|
Leucine
Lysine |
|
Phenylalanine:
Derivatives |
Phenylalanine-->
-->Tyrosine-->Thyroxine Tyrosine-->Dopa-->Melanin Dopa-->DA DA-->NE NE-->Epi |
|
Tryptophan:
Derivatives |
Tryptophan + B6-->Niacin-->NAD+/NADP+
Tryptophan + BH4-->5-HT-->Melatonin |
|
Histidine:
Derivatives |
Histidine + B6-->Histamine
|
|
Glycine:
Derivatives |
Glycine + B6-->Porphyrin-->Heme
|
|
Arginine:
Derivatives |
Arginine-->Creatine, Urea, Nitric Oxide
|
|
Glutamate:
Derivatives |
Glutamate-->Glutathione
Glutamate + B6-->GABA via GLUTAMATE DECARBOXYLASE (REQUIRES B6) |
|
Describe the first three steps of phenylalanine metabolism.
|
Phenylalanine-->Tyrosine via PHENYLALANINE HYDROXYLASE
Tyrosine-->Dopa (Dihydroxyphenylalanine) via TYROSINE HYDROXYLASE Dopa-->Dopamine via Dopa Decarboxylase REQUIRES B6 |
|
Effect of carbidopa on phenylalanine metabolism.
|
Carbidopa inhibits Dopa decarboxylase (Tyroine-->Dihydroxyphenylalanine aka 'dopa')
|
|
Phenylketonuria:
Pathophys Presentation Labs Treatment |
Due to dec'd phenylalanine hydroxylase or dec'd tetrahydrobiopterin cofactor (remember: Phenylalanine hydroxylase--Phenylalanine +THB-->Tyrosine + DHB)
Presntation: MR, growth retardation, seizures, fair skin, eczema, musty (mousy) body odor Phenylketones in urine (phenylacetate, phenylpyruvate, phenyllactate) Tx: Low phenylalanine (contained in aspartame) and high tyrorsine in diet |
|
Alkaptonuria:
Pathophys Presentation |
Deficiency of homogenetisic acid oxidase in degradative pathway of tyrosine to fumarate
Benign dz Findings: dark connective tissue, brown pigmented sclera, arthralgias (homogentisic acid is toxic to cartilage), urine turns black if left out for a while |
|
Albinism:
Pathophys |
Congenital deficiency of:
-Tyrosinase (inability to synthesize melanin from tyrosine)--Aut Recessive -Defective tyrosine transporters (dec'd amounts of tyrosine and thus melanin) |
|
Describe the possible fates of homocysteine.
|
|
|
Homocystinuria:
Pathophys Presentation Treatment |
3 forms:
1) Cysathionine synthase deficiency 2) Dec'd affinity of cystathionine synthase for pyridoxal phosphate 3) Homocysteine methyltransferase deficiency Findings: In'cd homocysteine in urine, MR, osteoporosis, tall stature, kyphosis, lens subluxation (downard and inward), atherosclerosis (stroke, MI) Tx: Dec'd methionine, inc'd cysteine in diet; supplement B12, folate, B6 |
|
Cystinuria:
Pathophys Treatment |
Hereditary defect of renal tubular amino acid transporter for cysteine, ornithine, lysine, and arginine in PCT of kidneys.
Excess cystine in urine can lead to the precipitation of cystine kidney sontes (staghorn calculi). Tx: Acetazolamide to alkalinize urine. |
|
Maple Syrup Urine Disease:
Pathophys |
Blocked degradation of BRANCHED amino acids (I LOVE VERMONT maple syrup--Isoleucine, Leucine, Valine)
Causes severe CNS defects, MR, death |
|
Hartnup Disease:
Pathophys Presentation |
Defective neural amino acid transporter on renal/interstitial epithelium causes tryptophan excretion in urine and dec'd absorption from gut
Leads to pellagra--diarrhea, dementia, dermatitis, death |
|
Which genetic syndrome:
1 000-fold risk of developing skin CA |
Xeroderma pigmentosa
|
|
Which genetic syndrome:
Alcoholics~ B1 defic. ~neurologic defects |
Pyruvate dehydrogenase def
|
|
Which genetic syndrome:
Abnormal collagen type I synthesis |
OI
|
|
Which genetic syndrome:
Absence of HGPRTase |
Lesch-Nyhan Syndrome
|
|
Which genetic syndrome:
Deficiency of aldolase B |
Fructose intolerance
|
|
Which genetic syndrome:
Defective excision repair ~ thymidine dimer formation |
Xeroderma Pigmentosa
|
|
Which genetic syndrome:
Deficiency of cystathionine synthase |
Homocysteinuria
|
|
Which genetic syndrome:
Heinz bodies |
G6PD Def
|
|
Which genetic syndrome:
Musty/mousy odor, albinism, MR, eczema |
PKU
|
|
Which genetic syndrome:
Galactose-1-P uridyl transferase deficiency—>MR, HSM, cataracts |
Galactosemia
|
|
Which genetic syndrome:
Rx- no NutraSweet, increased dietary tyrosine |
PKU
|
|
Which genetic syndrome:
Deficiency of tyrosinase |
Albinism
|
|
Which genetic syndrome:
Hyperextensible skin, loose joints, bleeding tendency |
Ehlers-Danlos
|
|
Which genetic syndrome:
Decreased NADPH due to lack of HMP enzyme |
G6PD Def
|
|
Which genetic syndrome:
Inherited defect in tubular amino acid transporter |
Cystinuria
|
|
Which genetic syndrome:
Rx- decreased dietary methionine, increased cystine + B6 |
Homocystinuria
|
|
Which genetic syndrome:
Deficiency in homogentisic acid oxidase |
Alkaptonuria (aka ochronosis)
|
|
Which genetic syndrome:
Hypoglycemia +jaundice + cirrhosis |
Fructose intolerant
|
|
Which genetic syndrome:
Self-mutilation, gout, aggression, choreoathetosis |
Lesch-Nyhan syndrome
|
|
Which genetic syndrome:
Blocked degradation of branched chain amino acids |
Maple Syrup Urine Dz
|
|
Which genetic syndrome:
Bloating, cramps, osmotic diarrhea |
Lactose Intolerance
|
|
Which genetic syndrome:
Rx- acetazolamide to alkalinize urine |
Cystinuria to prevent cysteine stones
|
|
Which genetic syndrome:
Deficiency results in a combined B and T cell deficiency |
Adenosine deaminase deficiency in SCID
|
|
Which genetic syndrome:
Rx- decreased fructose and sucrose intake |
Fructose intol
|
|
Which genetic syndrome:
Rx- increased intake of ketogenic nutrients (fats) |
Pyruvate DH def
|
|
Which genetic syndrome:
Dark brown urine, organs, and connective tissue; benign disease |
Alkaptonuria
|
|
Which genetic syndrome:
Multiple fractures + blue sclera |
OI
|
|
Which genetic syndrome:
Rx- exclude galactose and lactose from diet |
Galactosemia
|
|
What toxic product does amino acid catabolism generate?
Describe its removal. |
AA catabolism generates nitrogen (NH4+); converted urea and excreted by kidneys:
CO2 + NH4+-->Carbamoyl Phosphate via CARBAMOYL PHOSPHATE SYNTHETASE I (RLS!!!) TO MITOCHONDRIA!-->Citrulline (via ORNITHINE TRANSCARBAMOYLASE)-->-->-->-->Urea TO KIDNEY! |
|
Ornithine transcarbammoylase deficiency:
Pathophys Presentation |
Def. in the enzyme that converts Carbamoyl phosphate (product of NH4 breakdown) into Citrulline
interferes with bodys ability to eliminate ammonia Excess carbamoyl phosphate converted to orotic acid and found in blood/urine Dec'd BUN Syx of hyperammonemia |
|
Hyperammonemia:
Pathophys Presentation Treatment |
Can be acq'd (liver dz) or hereditary (urea cycle enzyme def)
Excess NH+ depletes alpha-ketoglutarate-->inhibition of TCA Results in tremor, slurred speech, somnolence, vomiting, cerebral edema, blurred vision Tx: LImit protein in diet Benzoate or phenylbutyrate (bind aa and lead to excretion) |
|
How are fatty acids synthesized.
Begin with Acetyl-CoA. |
AcetylCoa (in mitochondria)
-->Citrate Shuttle to Cell Cytoplasm -->AcetylCoa + CO2 + Biotin**-->Malonyl-CoA-->FA (plamitate) |
|
Describe how fatty acids are degraded.
|
FA + CoA-->Acyl-CoA (not ACETYL CoA) va Fatty Acid CoA Synthetase
Acyl-CoA-->Carnitine Shuttle-->Mitochondria -->Beta-oxidation to break down acetyl-CoA groups-->Ketone bodies OR TCA cycle |
|
Carnitine deficiency:
Effects |
Inability to transport LCFAs into mitochondria, resulting in toxic accumuln
Causes weakness, hypotonia, HYPOKETOTIC, HYPOGLYCEMIA |
|
Where is nascent HDL manufactured?
Describe its maturation and functions. |
Nascent HDL produced by liver and intestine.
Interacts with LCAT (lecithin-cholesterol acyltransferase) to become Matura HDL Mature HDL interacts with CETP (cholesterol ester transfer protein) to cholesterol bound can be dumped onto VLDL, IDL, LDL Mature HDL then reabsorbed and sent to liver |
|
Pancreatic lipase:
Role |
Degrades dietary TG in small intestine
|
|
Lipoprotein lipase:
Role |
Degrades TG circulating in chylomicrons and VLDLs
|
|
Hepatic TG lipase:
Role |
Degrades TG in IDL
|
|
Hormone-sensitive lipase:
Role |
Degrades TG stored in adipocytes
|
|
What are the differ apolipoproteins and what are their roles?
|
A-1: activates LCAT (nascent HDL-->Mature HDL)
B-100: binds to LDL receptor, mediates VLDL secretion C-II: Cofactor for lipoprotein lipase B-48: chylomicron secretion E: Extra (remnant) uptake B-48 E |
|
LDL vs HDL:
Role |
LDL is Lousy; transports cholesterol from liver to tissues
HDL is Healthy; transports cholesterol from periphery to liver |
|
Role of chylomicrons.
|
Delivers dietary TGs to peripheral tissue.
Delivers cholesterol to liver in form of chylomicron remnants. Secreted by intestinal epithelial cells. |
|
Familial hyperchylomicronemia:
Labs Pathophys |
Lipoprotein lipase deficiency (or altered apolipoprotein C-II)
Causes pancreatitis, HSM, xanthomas. No inc'd risk atherosclerosis. Labs: Elevated TG, cholesterol (elevated chylomicrons) |
|
Familial hypercholesterolemia:
Labs Pathophys |
Autosomal DOMINANT
Absent or low LDL receptors, HIGH LDL. Causes accelerated atherosclerosis, tendon xanthomas (Achilles). Labs; High cholesterol |
|
Familial hypertriglyceridemia:
Pathophys |
Hepative overproduction of VLDL; causes pancreatitis
|
|
What metabolic processes occur in the mitochondria?
|
FA oxidation (beta-oxidation)
Acetyl-Coa production TCA Ox-Phos |
|
What metabolic processes occur in the cytoplasm?
|
Glycolysis
FA synthesis HMP shunt Protein synthesis (RER) Steroid synthesis (SER) |
|
What metabolic processes occur in both the mitochondria AND cytoplasm?
|
HUGs take two:
Heme synthesis Urea cycle Gluconeogenesis |
|
Rate limiting enzyme:
Heme synthesis |
Aminolevulinate synthase
|
|
Rate limiting enzyme:
Bile acid synthesis |
7 alpha-hydroxylase
|
|
What are the essential amino acids?
|
PVT TIM HALL
Phe Val Thr Trp Isoleu Met His Arg Leu Lys |
|
What is the mechanism of action of lactulose?
|
Sugary syrup broken down in gut to create acidic environment to create ammonia to ammonium anion; traps it and pulls other ammonium to gut for excretion
|
|
Which amino acid is a precursor to:
Histamine |
Histidine
|
|
Which amino acid is a precursor to:
Porphyrin, heme |
Glycine
|
|
Which amino acid is a precursor to:
NO |
Arginine
|
|
Which amino acid is a precursor to:
GABA |
Glutamate
|
|
Which amino acid is a precursor to:
S-adenosyl-methionine |
Methioning
|
|
Which amino acid is a precursor to:
Creatine |
Arginine
|
|
Compare carbamoyl phosphate I to carbamoyl phosphate II.
|
CPS I:
Urea cycle Found in mitochondria Gets nitrogen from ammonium CPS II: Pyrimidine synthesis Found in cytosol Gets nitrogen from glutamine |
|
Rate-limiting enzyme:
Urea cycle |
Carbamoyl Synthetase I
|
|
Rate-limiting enzyme:
Hexose monophosphate pathway |
G6PD
|
|
Rate-limiting enzyme:
Fatty acid synthesis |
AcetylCoA Carboxylase
|
|
Rate-limiting enzyme:
beta-oxidation of fatty acids |
Carnitine acyltransferase
|
|
Rate-limiting enzyme:
Ketone body synthesis |
Hmg CoA Synthase
|
|
Rate-limiting enzyme:
Cholesterol synthesis |
Hmg CoA reductase
|
|
Rate-limiting enzyme:
Bile acid synthesis |
7-alpha-hydroxylase
|
|
Rate-limiting-enzyme:
Heme synthesis |
Aminolevulinate synthase
|
|
What deficiency causes familial hypercholesterolemia?
|
Def in LDL receptors
|
|
A patient with PKU should have diet low in phenylalanine.
What other dietary modifications should a patient with PKU make? |
Inc'd tyrosine in diet
Replacing THB cofactor |
|
A full-term neonate becomes mentally retarded and hyperactive and has a musty odor.
What is the diagnosis? |
PKU
|
|
A 2-year-old girl has an increase in abdominal girth, failure to thrive, and skin/hair depigmentation.
What is her diagnosis? |
Kwashiorkor
|
|
A middle-aged man has dark spots on his sclera and has noted that his urine turns black when left sitting for a period of time.
What is the diagnosis? |
Alkaptonuria
|
|
A patient has a genetic disease in which the treatment includes protein restriction to prevent mental retardation, ketoacidosis, and death.
What is the diagnosis? |
Maple Syrup Urine Dz
|
|
An 18-year-old female has moderate generalized abdominal pain, normal WBC, and no fever. She has
paresthesias in her lower extremities. What is her diagnosis? |
Acute intermittent porphyria
|
|
A 45-year-old male alcoholic gets blistering lesions in sun-exposed areas especially the dorsum of the hands. He also has hypertrichosis of the face.
What is the diagnosis? |
Porphyria Cutanea Tarda
|
|
What is the treatment for homocystinuria?
|
Tx:
Dec methionine Inc cystine Inc B6, ,B12, folate |
|
Cyclosporine:
Drug Class MOA AE |
immunosuppressant
Blocks differentiation/activation of T cells by inhibiting IL-2 production Nephrotoxic unless given mannitol diuresis |
|
Tacrolimus:
Drug Class MOA AE |
Immunosuppressant; inhibits secretion of IL-2 (no T cell diff/activation)
AE: significant! nephrotox, peripheral neuropathy, HTN, pleural effusion, hyperglycemia |
|
Sirolimus:
Drug Class MOA |
Immunosuppressant
Binds to mTOR, inhibits T-cell prolifern in response to IL-2 |
|
Which immunosuppressant:
Precursor of 6-mercaptopurine |
Azathioprine
|
|
Which immunosuppressant:
May prevent nephrotoxicity with mannitol diuresis |
Cyclosporine
|
|
Which immunosuppressant:
Antibody that binds to CD3 on T cells |
Murominab
|
|
Which immunosuppressant:
Antibody that binds IL-2 receptor on activated T cells |
Daclizumab
|
|
Which immunosuppressant:
Inhibits calcineurin –> loss of IL-2 production –> blockage ofT cell differentiation and activation |
Cyclosporine
|
|
Which immunosuppressant:
Binds FK-binding protein –> loss of IL-2 production |
Tacrolimus
|
|
Which immunosuppressant:
Binds FKBP-12 –> inhibition of mTOR –>inhibition ofT cell proliferation |
Sirolimus
|
|
Which immunosuppressant:
Metabolized by xanthine oxidase, therefore allopurinol increases its toxicity |
Azathioprine
|